Health Equity Digest – October 2023: Breast Cancer Rates for Black Women, Advancing Equity in Disaster Resilience

Welcome to Real Chemistry’s Health Equity Digest, a monthly summary of relevant highlights and emerging trends in today’s complex, ever-evolving health equity space.

Sign up here to receive the complete digest to your inbox each month.


Triple-negative breast cancer (TNBC) is a type of breast cancer that tends to grow quickly and has a higher likelihood of spreading and recurring after treatment compared to other types.  Black women are two times more likely than White women to have this aggressive form of cancer, which is most common in those younger than 40.

While the overall breast cancer death rate in the United States has dropped by 43% in the last 30 years, that is not the reality for Black women, who have a 4% lower incidence rate of breast cancer than White women. Breast cancer is, in fact, the leading cause of cancer death among Black and Hispanic women in the U.S.

Healthcare inequities contribute to these statistics. Black women are more likely to experience inadequate access to screenings, treatment and preventive and educational information. Historical barriers in the healthcare system, including limited access to education and clinical trial enrollment, also have a significant impact on outcomes for Black women.

Groups working to raise awareness in the space include Tigerlily Foundation, Triple-Negative Breast Cancer Foundation, Living Beyond Breast Cancer and TOUCH, the Black Breast Cancer Alliance.


READ:

MEET:

Rhea Boyd, MD, MPH, is a pediatrician, scholar and community health advocate, who discusses the intersections of race, tech innovation and health. She partners with community-serving and non-profit organizations to advance health equity and uses media to diversify data and voices to improve health outcomes. Recently, she helped develop THE CONVERSATION: Between Us, About Us, a national campaign aimed at delivering information about COVID vaccines directly to Black, Latinx and Spanish-speaking communities.


LEARN:
  • The Centers for Medicare & Medicaid Services (CMS) recently announced the States Advancing All-Payer Health Equity Approaches and Development Model (“States Advancing AHEAD” or “AHEAD Model”). Through this model, CMS will collaborate with participating states to reduce costs, improve population health and advance health equity. Up to 8 states will be awarded cooperative agreements to participate in the model. CMS is planning to release a Notice of Funding Opportunity (NOFO), with application information, in fall 2023. More details on the AHEAD model can be found here.

  • The Centers for Medicare & Medicaid Services (CMS) Office of Minority Health (OMH) announced awardees for the 2023 Minority Research Grant Program: Morgan State University (Racial Disparities in Maternal Child Health and the Role of Doulas in Reducing Disparities), University of New Mexico Health Sciences Center (Community Peer Education Project: Prisoner Health is Public Health) and California State University San Marcos Corporation (Community Schools Bridges2Health Research). The three recipients will each receive $333,000 for their projects, supporting CMS’ commitment to advancing health equity among the populations served.

  • As part of President Biden’s Unity Agenda, the White House Cancer Moonshot recently announced new actions and commitments to end cancer. Programs include:

    • New smoking cessation resources for underserved communities, including American Indian, Alaska Native and Black communities, to reduce cancer health disparities. NCI’s

      SmokeFree.gov initiative is extending a partnership with the Indian Health Service to collaborate with experts from the University of Minnesota School of Public Health and the American Indian Cancer Foundation to launch SmokeFreeNative, a text messaging program to help American Indian and Alaska Native adolescents and adults quit smoking, while honoring the significance of traditional tobacco.

    • A new nationwide health innovation network to bring cancer clinical trials to underserved communities and drive research progress. ARPA-H is announcing that its new ARPANET-H, a nationwide health innovation network to tackle pressing health challenges, will be deployed to accelerate clinical trials for cancer and other diseases. This new network will reach all 50 states and the District of Columbia, and create a continuous feedback loop with patients, providers, researchers and others that improves the goals, reach and data sharing capabilities across ARPA-H programs to foster breakthrough collaborations and advance equitable health outcomes. This new network will enable historically underserved populations to actively participate in clinical trials, improve equity in access to innovative cancer interventions and accelerate the agency’s work to drive breakthroughs in preventing, detecting and treating cancer and other diseases.

    • Komodo Health, a health data and technology startup, is announcing a new platform to measure cancer disease burden, map cancer outcomes and illuminate disparities in cancer care. Over the next two years, this effort will deliver insights to help public health officials, government agencies and patient advocacy organizations to directly support efforts to close the screening gap and decrease the impact of preventable cancers. Built on more than 330 million patient experiences, Komodo’s platform can be used to spotlight gaps in care, identify disparities in disease burden and understand the impact of cancer on discrete patient populations. This research will enable public and private partners to direct resources to reduce the burdens of lung cancer.

  • Across the U.S., gender-affirming care has been at the forefront of legislative discussions. In 2023, there have been more than 550 LGBTQ+ bills in 43 states. Since August 15, 2023, 80 bills have been signed into law, according to a new report from the Human Rights Campaign (HRC). Of 14,000 LGBTQ+ adults surveyed by HRC, nearly 80% of respondents feel their safety is threatened by recent bans and that they worsen harmful stereotypes.


RESEARCH:

WATCH:

LISTEN:
  • Heat waves and health, with Frederick Chen, MD: This episode discusses the connection between climate change and public health, highlighting the effects of extreme weather events, vector-borne illnesses and implications for patients of all ages.

  • CDC guidelines on new COVID vaccines and when to get the flu shot with Andrea Garcia, JD, MPH: This episode provides updates regarding the latest COVID, flu and RSV vaccines and explores the potential for a fall tripledemic, rising COVID-19 cases, new CDC data on drug overdose deaths and the blood supply shortage.

  • Maternal Health and Health Equity: This episode features Mary-Ann Etiebet, AVP for Health Equity at Merck and Lead of Merck for Mothers. The conversation explores ways to address disparities in maternal health outcomes and the contributions of the Merck for Mothers initiative.

  • Defining Health Equity with Dr. David Olawuyi Fakunle: The episode features Dr. David Olawuyi Fakunle, “Mercenary for Change," and Assistant Professor, Public Health, Morgan State University School of Community Health & Policy. This conversation explores the stressors within the "built" environment, societal manifestations of racism and the use of arts and culture to strengthen health, equity and, ultimately, liberation.

  • Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation: This episode of Managed Care Cast explores the challenges and disparities in lung cancer risk factor documentation, as well as the potential for improvement.


ATTEND:

Sign up here to learn more and to receive the full Health Equity Digest to your inbox each month.